Gamma vaccines has entered a collaboration agreement with Capricorn Technologies GmBH (Austria) and Aptum Adjuvants Ltd (UK) to investigate and develop vaccines that marry Gamma Vaccines manufacturing technology with Capricorn’s novel vaccines and Aptum’s innovative approach to increasing vaccine effectiveness.
05/10/2024
Gamma Vaccines acquires IP to develop NDV vaccine
Gamma Vaccines has signed a deed of assignment with the University of Adelaide for the rights to commercialise…